OD

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis

Retrieved on: 
Tuesday, March 5, 2024

“Mite Party” is designed to elevate consumer awareness of Demodex blepharitis through relatable messaging and compelling visuals to encourage patients who may have Demodex blepharitis to seek out an eye care provider for screening.

Key Points: 
  • “Mite Party” is designed to elevate consumer awareness of Demodex blepharitis through relatable messaging and compelling visuals to encourage patients who may have Demodex blepharitis to seek out an eye care provider for screening.
  • “We are committed to increasing Demodex blepharitis education and awareness so that patients more effectively understand their disease and are motivated to seek treatment,” said Aziz Mottiwala, Chief Commercial Officer of Tarsus.
  • We look forward to advancing this novel campaign with the goal of helping as many patients with Demodex blepharitis as possible.”
    Demodex blepharitis occurs when Demodex mites – the most common ectoparasites found on humans – overpopulate on the eyelids.
  • “Mite Party” will officially launch on the XDEMVY Facebook page (@xdemvyrx) with a live event designed to “break up the mite parties” on Demodex blepharitis patients’ eyelids.

AllBright Alliance Welcomes Industry Powerhouses—British Airways, Guggenheim Investments and Tapestry (Coach, Kate Spade, Stuart Weitzman)—as It Marks a Year of Substantial Growth and Gender Equity Impact

Retrieved on: 
Friday, March 8, 2024

The milestone comes one year after the programme's inception, highlighting a period of significant growth and impact in supporting gender equity across the world.

Key Points: 
  • The milestone comes one year after the programme's inception, highlighting a period of significant growth and impact in supporting gender equity across the world.
  • With the addition of these new partners, AllBright Alliance now reaches over 750,000 employees across various sectors.
  • “We are thrilled to be partnering with AllBright, underscoring our significant commitment to strengthening gender equality in the workplace,” said Dina DiLorenzo, Co-President of Guggenheim Investments.
  • This helps us become a more sustainable organisation and further reduce our gender pay gap.”
    For more information on AllBright Alliance visit www.allbrightcollective.com/business ; or for interview/ further commentary, contact [email protected]

SightMD Welcomes Cynthia Zara, OD to its expert team in New York

Retrieved on: 
Monday, March 4, 2024

HAUPPAUGE, N.Y., March 4, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.
  • HAUPPAUGE, N.Y., March 4, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Cynthia Zara, OD to its expert team.
  • Cynthia Zara, OD is a board-certified optometrist providing dilation exams, contact lenses and eyeglasses, dry eye treatments, and more.
  • When asked what she is looking forward to most about joining the SightMD Team, Dr Zara said "I am excited to be joining SightMD in Hamptons Bays and Southampton.

CathSOLVER™ simplifies MicroCatheter Design Development

Retrieved on: 
Friday, March 1, 2024

SAN ANTONIO, Feb. 29, 2024 /PRNewswire-PRWeb/ -- Roth Technologies, LLC announces the immediate release of the CathSOLVER™ function add-in for the CathCAD® Standard software for all licensed Users.

Key Points: 
  • CathCAD® modernized the microcatheter design process in 2012 by solving the forward problem catheter design problem numerically, that is, given the geometry and the physical characteristics of the design, the Software computed the functional characteristics of the design including longitudinal rigidity, flexural rigidity, torsional rigidity, kink radius, and the applicable failure modes.
  • CathSOLVER™ solves the inverse catheter design problem, that is, given a set of desired characteristics (ID, OD, number of layers, and desired physical attributes), the Software will compute and provide the "best" design that meets the catheter design requirements.
  • When the applicable design parameters are fully developed by the User, the CathSOLVER™ algorithm executes hundred of designs iterations resulting in the Software determining the best design given the User's defined constraints.
  • When the applicable design parameters are fully developed by the User, the CathSOLVER™ algorithm executes hundred of designs iterations resulting in the Software determining the best design given the User's defined constraints.

Foundation Fighting Blindness Hosting Webinar for Eye Care Professionals: Best Clinical Practices for Patients with Inherited Retinal Diseases

Retrieved on: 
Tuesday, February 13, 2024

COLUMBIA, Md., Feb. 13, 2024 /PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host a webinar for eye care professionals on the best practices for managing their patients with inherited retinal diseases (IRDs), including retinitis pigmentosa, Usher syndrome, Stargardt disease, and Leber congenital amaurosis. This webinar will be a part of the March Envisioning a Path to Hope initiative, raising awareness among eye care professionals for the valuable resources the Foundation provides IRD patients and caregivers.

Key Points: 
  • This webinar will be a part of the March Envisioning a Path to Hope initiative, raising awareness among eye care professionals for the valuable resources the Foundation provides IRD patients and caregivers.
  • "With nearly 50 clinical trials underway for emerging IRD therapies and no-cost genetic testing available for patients, eye care professionals can do so much to help IRD patients on their challenging journeys," says Michelle Glaze, director of professional outreach, Foundation Fighting Blindness.
  • "We are delighted to host this informative webinar to empower eye doctors to communicate hope and a path forward for their IRD patients and families."
  • She treats patients in the clinical departments of Acquired Brain Injury and Low Vision Rehabilitation, where she also conducts genetic testing for inherited eye conditions.

OCLI Vision Welcomes Dr. Kinnari Patel, OD, to the Northeast Philadelphia, Pennsylvania Area to Expand Access to Great Eye Care in the Region

Retrieved on: 
Monday, February 5, 2024

GARDEN CITY, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- OCLI Vision is thrilled to announce the latest addition to our team, Dr. Kinnari Patel, OD, who will be exclusively serving the Northeast Philadelphia location starting February 5th, 2024.

Key Points: 
  • Dr. Patel, a highly accomplished optometrist, brings over a decade of experience and expertise in primary eye care.
  • "I am delighted to join OCLI Vision team, where I can leverage my decade-long experience to provide outstanding eye care to patients.
  • I provide patient care for all aspects of primary eye care with focus on Dry Eye and Ocular Surface Disease."
  • I provide patient care for all aspects of primary eye care with focus on Dry Eye and Ocular Surface Disease.

Eye Health America Announces Newest Acquisition of Loris Eye Associates

Retrieved on: 
Thursday, February 1, 2024

Welcome Dr. Tracy Ray and Loris team to our exceptional roster of eye care professionals.

Key Points: 
  • Welcome Dr. Tracy Ray and Loris team to our exceptional roster of eye care professionals.
  • Founded in 2018 by LLR Partners, Clemson Eye, and The Eye Associates, EHA is led by experienced eye care leadership, providing superior support to partner practices.
  • Eye Health America (EHA) is a leading eyecare provider focused on partnering with culturally aligned ophthalmology practices, optometry practices and ambulatory surgery centers across the Southeast U.S. to provide superior strategic, financial, and operational support for best-in-class eye care.
  • Member practices include Clemson Eye, Piedmont Surgery Center, EHA Surgery Center Seneca, The Surgery & Laser Center, Carolinas Centers for Sight, Florence Surgery and Laser Center, Southeast Retina Center, Augusta Retina Laser Surgicare, The Eye Associates, The Eye Associates Surgery Center, EHA Surgery Center Sarasota, Eye Centers of Florida, Surgicare Center, Updegraff Laser Vision, Tampa Bay Eye Surgery Center, West Georgia Eye Care Center, Eye Surgery Center of West Georgia, and many other top eyecare providers.

SightMD New York Welcomes Clearview Eye Surgery to It's Expert Team

Retrieved on: 
Thursday, January 25, 2024

HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery. Through this strategic partnership Clearview's practice locations at 1825 Riverside Drive, Suite 1B New York, NY 10034, 1200 Waters Place, Suite 304 Bronx, NY 10461 and 132-15 41st Avenue CC Flushing , NY 11355 will expand SightMD's presence by adding three locations and five providers, growing SightMD's current footprint to 40+ locations and 85+ providers across New York.

Key Points: 
  • HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery.
  • - Dr. John J. Kim, Founder of Clearview Eye Surgery
    "We are excited to welcome Clearview Eye Surgery into the SightMD family.
  • Clearview Eye Surgery is dedicated to providing state of the art, professional and personalized eye care to all of our patients to ensure the best possible outcome.
  • Thousands of people have trusted their award-winning team with their families' eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD.

SightMD Welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD

Retrieved on: 
Friday, January 19, 2024

HAUPPAUGE, N.Y., Jan. 19, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.
  • HAUPPAUGE, N.Y., Jan. 19, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.
  • Jeremy Liang, OD is a board-certified optometrist providing dilated exams, contact lenses and eyeglasses, dry eye treatments, and more.
  • Brian Berliner, OD is a board certified optometrist who has been practicing and providing eye care since 1983.

Leading with Clarity: BOSA Equips Eye Doctors for Booming Dry Eye Market

Retrieved on: 
Tuesday, January 16, 2024

NILES, Ill., Jan. 16, 2024 /PRNewswire-PRWeb/ -- M&S Technologies, a leader in computerized vision testing in collaboration with Bruder Healthcare, renowned for dry eye solutions announce the launch of the M&S Bruder Ocular Surface Analyzer (BOSA). The all-in-one innovative device represents an advancement in dry eye assessment and is poised to be a necessity for eye care practices treating ocular surface disease (OSD), including dry eye syndrome. In only 15 seconds per eye, BOSA captures and provides OSD test results. "With the system's unmatched speed, accuracy, and ease of use, doctors can manage dry eye patients more efficiently and effectively, improving outcomes through better data and boosting revenues through time savings," explains Brent Jones of Hilco Vision, parent company of M&S Technologies and Bruder Healthcare.

Key Points: 
  • The all-in-one innovative device represents an advancement in dry eye assessment and is poised to be a necessity for eye care practices treating ocular surface disease (OSD), including dry eye syndrome.
  • "The Bruder Ocular Surface Analyzer is the most comprehensive "one-stop" instrument available to document Dry Eye Disease."
  • BOSA consolidates these diverse tests into one efficient device, offering eye doctors a comprehensive solution within their exam rooms.
  • It is the answer for both the established Dry Eye practice looking to improve efficiency and the eye care practice looking to start a Dry Eye clinic," said Darrell White, MD of SkyVision Centers.